SPOTLIGHT -
Slideshow
Author(s):
These concise summaries highlight the latest findings and potential remedies.
Esketamine CIII Nasal Spray: First and Only Monotherapy for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Why We Need a New Class of Antidepressants
Treating ‘Morally Objectionable’ Patients
Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder